Henry E. Pelish's most recent trade in Nuvalent Inc - Ordinary Shares - Class A was a trade of 17,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 83,388 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 97.33 per share. | 05 Jan 2026 | 1,369 | 66,077 | - | 97.3 | 133,245 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 97.96 per share. | 05 Jan 2026 | 1,137 | 68,738 | - | 98.0 | 111,381 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 96.75 per share. | 05 Jan 2026 | 1,106 | 67,446 | - | 96.8 | 107,006 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 96.85 per share. | 05 Jan 2026 | 660 | 69,875 | - | 96.9 | 63,921 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 96.06 per share. | 05 Jan 2026 | 513 | 70,535 | - | 96.1 | 49,279 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 98.40 per share. | 05 Jan 2026 | 189 | 65,888 | - | 98.4 | 18,598 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 98.52 per share. | 05 Jan 2026 | 186 | 68,552 | - | 98.5 | 18,325 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 5,085 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 22 Dec 2025 | 5,085 | 71,048 | - | 1.1 | 5,492 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 90.04 per share. | 15 Oct 2025 | 14,205 | 65,963 | - | 90.0 | 1,279,018 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 15 Oct 2025 | 7,495 | 77,126 | - | 27.9 | 208,736 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,495 | 13,156 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 3,668 | 10,569 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 15 Oct 2025 | 3,668 | 69,631 | - | 18.9 | 69,435 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 3,042 | 24,058 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 15 Oct 2025 | 3,042 | 80,168 | - | 72.4 | 220,089 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 89.81 per share. | 13 Oct 2025 | 7,637 | 65,963 | - | 89.8 | 685,879 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 4,168 | 21,528 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 13 Oct 2025 | 4,168 | 71,800 | - | 27.9 | 116,079 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 1,800 | 27,100 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 13 Oct 2025 | 1,800 | 73,600 | - | 72.4 | 130,230 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 1,669 | 14,968 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 13 Oct 2025 | 1,669 | 67,632 | - | 18.9 | 31,594 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 84.98 per share. | 13 Oct 2025 | 1,167 | 67,229 | - | 85.0 | 99,172 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 877 | 20,651 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 13 Oct 2025 | 877 | 67,571 | - | 27.8 | 24,424 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 86.11 per share. | 13 Oct 2025 | 866 | 66,363 | - | 86.1 | 74,571 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 825 | 14,025 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 13 Oct 2025 | 825 | 68,396 | - | 29.3 | 24,197 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 731 | 14,237 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 13 Oct 2025 | 731 | 66,694 | - | 18.9 | 13,838 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 87.39 per share. | 13 Oct 2025 | 400 | 65,963 | - | 87.4 | 34,956 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 78.83 per share. | 10 Sep 2025 | 3,725 | 65,963 | - | 78.8 | 293,642 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 2,117 | 14,850 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 10 Sep 2025 | 2,117 | 69,688 | - | 29.3 | 62,092 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 877 | 25,696 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 10 Sep 2025 | 877 | 67,571 | - | 27.8 | 24,424 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 10 Sep 2025 | 731 | 66,694 | - | 18.9 | 13,838 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 731 | 16,637 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2025 | 3,000 | 5,085 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 29 Aug 2025 | 3,000 | 65,963 | - | 1.1 | 3,240 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2025 | 2,007 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. | 29 Aug 2025 | 2,007 | 62,963 | - | 0.9 | 1,746 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 74.85 per share. | 07 Aug 2025 | 5,500 | 60,956 | - | 74.9 | 411,675 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 3,892 | 16,967 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 07 Aug 2025 | 3,892 | 66,456 | - | 29.3 | 114,152 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 877 | 26,573 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 07 Aug 2025 | 877 | 62,564 | - | 27.8 | 24,424 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 07 Aug 2025 | 731 | 61,687 | - | 18.9 | 13,838 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 731 | 17,368 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.94 per share. | 09 Jul 2025 | 5,260 | 61,196 | - | 79.9 | 420,484 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 4,440 | 20,859 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 09 Jul 2025 | 4,440 | 66,456 | - | 29.3 | 130,225 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.08 per share. | 09 Jul 2025 | 1,945 | 61,156 | - | 81.1 | 157,701 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 878 | 27,450 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 09 Jul 2025 | 878 | 62,016 | - | 27.8 | 24,452 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 80.92 per share. | 09 Jul 2025 | 240 | 60,956 | - | 80.9 | 19,421 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.90 per share. | 09 Jul 2025 | 200 | 60,956 | - | 81.9 | 16,380 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 182 | 18,099 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 09 Jul 2025 | 182 | 61,138 | - | 18.9 | 3,445 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.87 per share. | 25 Jun 2025 | 8,630 | 63,101 | - | 79.9 | 689,278 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 25 Jun 2025 | 4,953 | 71,731 | - | 29.3 | 145,271 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2025 | 4,953 | 27,122 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 25 Jun 2025 | 3,677 | 66,778 | - | 27.8 | 102,404 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2025 | 3,677 | 28,675 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.92 per share. | 25 Jun 2025 | 2,170 | 63,101 | - | 79.9 | 173,426 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 25 Jun 2025 | 1,823 | 65,271 | - | 29.3 | 53,469 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2025 | 1,823 | 25,299 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 25 Jun 2025 | 347 | 63,448 | - | 27.9 | 9,664 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2025 | 347 | 28,328 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.82 per share. | 06 Jun 2025 | 200 | 63,101 | - | 79.8 | 15,964 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 100 | 32,352 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 100 | 32,075 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 06 Jun 2025 | 100 | 63,301 | - | 29.3 | 2,933 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 06 Jun 2025 | 100 | 63,201 | - | 27.9 | 2,785 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 3,120 | 2,007 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. | 31 Jan 2025 | 3,120 | 63,101 | - | 0.9 | 2,714 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 18,750 | 62,464 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 80.54 per share. | 06 Jan 2025 | 1,343 | 59,981 | - | 80.5 | 108,165 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 78.28 per share. | 06 Jan 2025 | 712 | 61,752 | - | 78.3 | 55,735 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.33 per share. | 06 Jan 2025 | 428 | 61,324 | - | 79.3 | 33,953 | Class A Common Stock |
| Nuvalent Inc (Class A) | Pelish Henry E. | Chief Scientific Officer | 16 Dec 2024 | 5,914 | 39,214 | - | 0.6 | 3,844 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Pelish Henry E. | Chief Scientific Officer | 16 Dec 2024 | 5,914 | 0 | - | - | Stock Option (Right to Buy) | ||
| Nuvalent Inc (Class A) | E. Henry Pelish | Chief Scientific Officer | 16 Dec 2024 | 4,500 | 43,714 | - | 0.9 | 3,915 | Class A Common Stock | |
| Nuvalent Inc (Class A) | E. Henry Pelish | Chief Scientific Officer | 16 Dec 2024 | 4,500 | 5,127 | - | - | Stock Option (Right to Buy) | ||
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 7,812 | 33,400 | - | 102.5 | 801,042 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 5,513 | 41,212 | - | 101.2 | 557,805 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 4,105 | 54,722 | - | 96.6 | 396,584 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 4,094 | 46,725 | - | 100.3 | 410,424 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 3,754 | 60,375 | - | 94.8 | 355,879 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 3,197 | 51,525 | - | 97.5 | 311,835 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 1,966 | 64,129 | - | 93.3 | 183,330 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 1,548 | 58,827 | - | 95.4 | 147,617 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 706 | 50,819 | - | 98.2 | 69,343 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 16 Sep 2024 | 100 | 33,300 | - | 102.8 | 10,280 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 23 Aug 2024 | 10,500 | 66,095 | - | 85.1 | 893,340 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 09 Jul 2024 | 18,600 | 18,600 | - | - | Stock Option (Right to Buy) | ||
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 09 Jul 2024 | 13,100 | 76,595 | - | 0 | Class A Common Stock |